Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

58.93 +0.39 (+0.67%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

44 45 Next >

GSK's Jemperli Plus Chemo Combo Scores FDA Approval As First New Frontline Treatment For Certain Type Of Endometrial Cancer ↗

August 01, 2023

The FDA approved GSK plc's (NYSE: GSK) Jemperli (dostarlimab) in combination with carboplatin and paclitaxel, followed by Jemperli as a single agent for primary advanced or recurrent endometrial cancer...

Via Benzinga

Jemperli (dostarlimab-gxly) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer

July 31, 2023

From GSK plc

Via Business Wire

If You Can Only Buy One Dividend Stock, It Better Be One of These 7 Names ↗

July 30, 2023

Here are seven of the best dividend stocks to consider immediately. Better, each of these stocks have strong, stable businesses.

Via InvestorPlace

3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes ↗

July 30, 2023

Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits.

Via InvestorPlace

Is GSK Stock Worth Buying Right Now? ↗

July 29, 2023

GSK stock could be a bargain.

Via The Motley Fool

A Look Into GSK's Debt ↗

July 17, 2023

Via Benzinga

GSK's RSV Vaccine Scores Approval In UK For Older Adults ↗

July 10, 2023

The U.K.

Via Benzinga

GSK Says 'Excellent' Q2 Performance Boosted By Vaccine & HIV Drug Sales, Raises 2023 Outlook ↗

July 26, 2023

GSK plc (NYSE: GSK) reported Q2 FY23 sales of £7.18 billion ($8.97 billion), up 4% Y/Y on t

Via Benzinga

Pharma Giant GSK Beats Second-Quarter Goals On Growth In Vaccines, General Medicines ↗

July 26, 2023

Pharmaceutical giant GSK beat expectations for the second quarter and raised its forecast for the full year. GSK stock rose on the news.

Via Investor's Business Daily

Tesla's India Move, Adidas Receives Orders For Massive Unsold Yeezy Inventory, Spotify Raises Subscription Prices: Today's Top Stories ↗

July 24, 2023

Wall Street Journal

Via Benzinga

GSK-Pfizer Backed HIV-Focused Unit ViiV Healthcare's Cabotegravir Injected Drug, Tablets Secure European Backing For Approval ↗

July 24, 2023

ViiV Healthcare received a positive opinion from the European Medicines Agen

Via Benzinga

(GSK) - Analyzing GSK's Short Interest ↗

July 07, 2023

Via Benzinga

Better Artificial Intelligence Stock: GSK or Eli Lilly? ↗

June 28, 2023

Which of these AI-powered drugmakers is the better buy right now?

Via The Motley Fool

The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023 ↗

July 21, 2023

Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market.

Via InvestorPlace

Why Shares of Vir Biotechnology Are Plunging Thursday ↗

July 20, 2023

The company had disappointing trial news for one of its lead therapies.

Via The Motley Fool

Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business ↗

July 13, 2023

HC Wainwright has upgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) to Buy from Sell, with a price target of

Via Benzinga

7 Stocks That AI Says Will Make You a Millionaire by 2025 ↗

July 13, 2023

These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio.

Via InvestorPlace

3 Healthcare Stocks With Healthy Dividends ↗

July 13, 2023

These pharmaceutical companies all combine relatively high dividends with safe payout ratios.

Via The Motley Fool

GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US

July 13, 2023

From GSK plc

Via Business Wire

3 No-Brainer Stocks to Buy With $50 Right Now ↗

July 12, 2023

You don't need a treasure chest full of cash to begin building wealth on Wall Street.

Via The Motley Fool

Why Are NanoViricides Shares Gaining Today ↗

July 11, 2023

NanoViricides Inc (NYSE: NNVC) shares are trading higher after the company reported preclinical data from an antiviral clinical drug candidate for

Via Benzinga

Meta's Threads Hits 100M Users In Five Days, Foxconn Pulls Out From $19.5B Semiconductor India JV, Novo Nordisk's Weight-Loss Medications Under European Investigation Over Suicidal Risks: Today's Top Stories ↗

July 10, 2023

Benzinga

Via Benzinga

From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs ↗

July 07, 2023

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as...

Via Benzinga

Analyst Creates Bullish Pitch For WAVE Life Sciences, Says It Is 'Leader To Clinic In RNA Editing' ↗

July 05, 2023

Raymond James has initiated coverage on WAVE Life Sciences Ltd (NASDAQ: WVE) with a price target of $9 and

Via Benzinga

Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit ↗

July 05, 2023

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale.

Via Benzinga

Moderna Initiates Regulatory Application Process Seeking Approval For Its RSV Vaccine In Older Adults ↗

July 05, 2023

Moderna Inc (NASDAQ: MRNA) provided an update on regulatory submissions for the mRNA-1345 vaccine to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease in

Via Benzinga

Haleon Contemplates Sale of Non-Core Businesses, Including Nicotinell Brand: A Strategy Shift Towards Core Products ↗

July 05, 2023

Haleon Plc (NYSE: HLN), a consumer health company, is reportedly considering divesting some smoking cessation products as part of a strategy to sell non-core businesses.

Via Benzinga

First US Trial Over Zantac's Alleged Cancer-Causing Properties Set For November In California ↗

July 03, 2023

The initial U.S. court trial concerning the antacid medication Zantac is slated to commence on November 13 in a state court in California, as stated by a lawyer representing the plaintiffs.

Via Benzinga

Drugmaker GSK: Becoming a Healthier Value Stock

June 27, 2023

Up more than 25% in the last nine months, U.K. pharmaceutical company GSK PLC is slowly regaining favor with investors after the GSK lawsuit.

Via MarketBeat

Topics Lawsuit

Baidu Says Ernie Bot Beats ChatGPT, Meta's WhatsApp Business Soars Past 200M Users, Walgreens Earnings Disappointment: Today's Top Stories ↗

June 27, 2023

CNBC ChatGPT Vs. Baidu's Ernie Bot - Chinese Tech Giant Says Ernie Beat ChatGPT

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Starting at $3.75/week.

Subscribe Today